Precursor Cell Lymphoblastic Leukemia-Lymphoma — Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia
Citation(s)
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia